Saint G, Semple M, Sinha I, Hawcutt D
Paediatr Drugs. 2018; 20(3):209-214.
PMID: 29302790
PMC: 5954054.
DOI: 10.1007/s40272-017-0281-x.
Devereux G, Cotton S, Barnes P, Briggs A, Burns G, Chaudhuri R
Trials. 2015; 16:267.
PMID: 26058585
PMC: 4465017.
DOI: 10.1186/s13063-015-0782-2.
Mazza J
Can Fam Physician. 2011; 28:1799-803.
PMID: 21286561
PMC: 2306700.
Brashear R, Nelson R, Glick M, Oei T, DeAtley R
Lung. 1980; 158(2):101-9.
PMID: 7431995
DOI: 10.1007/BF02713709.
Cusack B, Kelly J, Lavan J, Noel J, OMalley K
Br J Clin Pharmacol. 1980; 10(2):109-14.
PMID: 7426272
PMC: 1430051.
DOI: 10.1111/j.1365-2125.1980.tb01726.x.
Disposition and clinical pharmacokinetics of microcrystalline theophylline.
Jonkman J, BERG W, Schoenmaker R, de Zeeuw R, Greving J, ORIE N
Eur J Clin Pharmacol. 1980; 17(5):379-84.
PMID: 7418716
DOI: 10.1007/BF00558452.
Influence of age on theophylline clearance in patients with chronic obstructive pulmonary disease.
Bauer L, Blouin R
Clin Pharmacokinet. 1981; 6(6):469-74.
PMID: 7318306
DOI: 10.2165/00003088-198106060-00005.
Dose-dependency of theophylline clearance and protein binding.
Fleetham J, Bird C, Nakatsu K, Wigle R, Munt P
Thorax. 1981; 36(5):382-6.
PMID: 7314008
PMC: 471514.
DOI: 10.1136/thx.36.5.382.
A comparison of the pharmacokinetics of theophylline in asthmatic children in the acute episode and in remission.
Arnold J, Hill G, Sansom L
Eur J Clin Pharmacol. 1981; 20(6):443-7.
PMID: 7286054
DOI: 10.1007/BF00542097.
Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
Horai Y, Ishizaki T, Sasaki T, Watanabe M, KABE J
Eur J Clin Pharmacol. 1982; 23(2):111-21.
PMID: 7140800
DOI: 10.1007/BF00545964.
Pharmacokinetics of theophylline in patients following short-term intravenous infusion.
Steinijans V, EICKE R, Ahrens J
Eur J Clin Pharmacol. 1982; 22(5):417-22.
PMID: 7117353
DOI: 10.1007/BF00542546.
Relation of oral dose of oxtriphylline to serum theophylline level.
Guyatt G, Desai S
Can Med Assoc J. 1981; 125(12):1336-8.
PMID: 7034918
PMC: 1862761.
Bioavailability and pharmacokinetics of theophylline following plain uncoated and sustained-release dosage forms in relation to smoking habit. II. Multiple dose study.
Ishizaki T, Horai Y, Sasaki T, Chiba K, Ohnishi A, Suganuma T
Eur J Clin Pharmacol. 1983; 24(3):361-9.
PMID: 6861849
DOI: 10.1007/BF00610056.
Sustained serum theophylline concentrations during chronic twice daily administration of a slow release preparation.
Jackson S, Wright J
Eur J Clin Pharmacol. 1983; 24(2):205-8.
PMID: 6840168
DOI: 10.1007/BF00613818.
Slow release theophyllines and chronic bronchitis.
COCHRANE G
Br Med J (Clin Res Ed). 1984; 289(6459):1643-4.
PMID: 6439357
PMC: 1443832.
DOI: 10.1136/bmj.289.6459.1643.
Doses of aminophylline given intravenously in casualty department and resulting serum theophylline concentrations.
Munro C, Prowse K
Br Med J (Clin Res Ed). 1984; 289(6441):354-5.
PMID: 6432095
PMC: 1442366.
DOI: 10.1136/bmj.289.6441.354-a.
Clinical trials in asthma.
Rees J
Br Med J (Clin Res Ed). 1983; 287(6389):376-7.
PMID: 6409313
PMC: 1548943.
DOI: 10.1136/bmj.287.6389.376.
A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
Hendeles L, Iafrate R, Weinberger M
Clin Pharmacokinet. 1984; 9(2):95-135.
PMID: 6370542
DOI: 10.2165/00003088-198409020-00001.
A critique of dosing strategies for beta-2 adrenergic agents and theophylline.
Jenne J
Lung. 1981; 159(6):295-314.
PMID: 6117677
DOI: 10.1007/BF02713930.
Comparison of drug dosing methods.
Burton M, Vasko M, Brater D
Clin Pharmacokinet. 1985; 10(1):1-37.
PMID: 3882303
DOI: 10.2165/00003088-198510010-00001.
